Safety Prefilled Syringe Market, By Type (Disposable Prefilled Syringes and Reusable Prefilled Syringes), By Barrel Type (Dual Chambered, Customized Prefilled Syringes, and Single Chambered), By Product Type (Plastic-based Prefilled Syringes and Glass-based Prefilled Syringe), By Application (Hormonal Disorders, Oncology, Auto-immune Diseases, Diabetes, Anemia, and Other), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029

Prefilled syringes are mainly ready-to-use pharmaceutical products. They are used to provide medication to the patients. Safety prefilled syringes are disposable or reusable syringes which enclose substance or liquid use to administer to a patient. These syringes help to deliver the precise dose of the drug and aid in avoiding the chances of overdosing. Further, they are also utilized to deliver vaccines where the precise dose is needed. Due to the rapid adoption of technology, the European market for prefilled syringes is comparatively more mature compared to the US market. A number of key players are involved in the manufacturing of the advance syringes which would enhance the route of the administration of the drug. The safety prefilled syringe market accounted for US$ 3.7 billion in 2019 and is estimated to be US$ 7.8 billion by 2029 and is anticipated to register a CAGR of 7.9%.

Due to the outbreak of Covid-19 pandemic globally, countries are facing major shortages of essential life-saving devices and other essential medical supplies to test for the virus. Diagnostics virology entities are under immense pressure to offer reliable testing kits, and there is a surge in demand for in-vitro or point-of-care testing capacities by labs across the globe. The report will account for Covid19 as a key market contributor.

Increasing prevalence of the various chronic diseases

Rising prevalence of the various chronic diseases such as cancer, diabetes, hormonal diseases and others is the major factor boosting growth of the safety prefilled syringe market. According to the data published by WHO, in 2016, 422 million people globally are suffering from diabetes. Further, rapidly growing occurrence of several diseases has increased the demand for the better treatment option and eventually supported the growth of the target market. In addition, rising government support, increasing healthcare expenditure, and growing preference by individuals for vaccines has driven the growth of the market.

Fast-paced development

Advancement in biopharmaceutical industry has led to progressive impact on the demand for safety prefilled syringes as they help to reduce the loss of potency while transferring biopharmaceuticals in different containers. Few biological drugs that are possibly packed in prefilled syringes include small, as well as large, molecules such as monoclonal antibodies and antibody drug conjugates.

However, high costs of syringes and cases associated with cross-contamination between primary packaging and drugs present within the syringe are major factors limiting the growth of the market. Additionally, presence of effective and better alternative such as nano-patches and other non-invasive methods for drug administration are also answerable for slowing the target market growth.

The safety prefilled syringe market is segmented based on type, barrel type, product type, application, and region.

On the basis of type, the safety prefilled syringe market is segmented into disposable prefilled syringes and reusable prefilled syringes. On the basis of barrel type, the market is classified into dual chambered, customized prefilled syringes, and single chambered. Based on product type, the target market is segmented into plastic-based prefilled syringes and glass-based prefilled syringe. On the basis of application, the target market is segmented into hormonal disorders, oncology, auto-immune diseases, diabetes, anemia, and other.

 Regional Insights:

On region the safety prefilled syringe market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is presently leading the market due to increasing demand for prefilled syringes in the region. Additionally, strong presence of major market players such as Schott Group, Gerresheimer AG, and Owen Mumford Ltd. is also likely to help propel the region’s growth. Further, growing number of surgeries owing to several factors and faster approval procedures by various regulatory authorities are the factors projected to boost the Europe regional market. The Asia Pacific market is anticipated to grow at a lucrative CAGR in the coming years. Availability of untapped growth opportunities and rapidly developing economies, such as India and China, are the key factors stimulating the region’s expansion. Besides, growing prevalence of various chronic diseases and large patient population are anticipated to boost the sector growth in the region.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at , regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the safety prefilled syringe market report based on type, barrel type, product type, application, and region.

Safety Prefilled Syringe Market, By Type:

• Disposable Prefilled Syringes
• Reusable Prefilled Syringes

Safety Prefilled Syringe Market, By Barrel Type:

• Dual Chambered
• Customized Prefilled Syringes
• Single Chambered

Safety Prefilled Syringe Market, By Product Type:

• Plastic-based Prefilled Syringes
• Glass-based Prefilled Syringe

Safety Prefilled Syringe Market, By Application:

• Hormonal Disorders
• Oncology
• Auto-immune Diseases
• Diabetes
• Anemia
• Other

Safety Prefilled Syringe Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating in the safety prefilled syringe market includes Schott AG, Gerresheimer AG, West Pharmaceutical Services, Inc., Becton, Dickinson and Company, Vetter Pharma International GmbH, Catalent, Inc., Shandong Weigao Group Medical Polymer Company Limited, Nipro Corporation, Medpro, Inc., and Stevanato Group SpA. These prominent players involved in the target market focus on deploying investments to expand their manufacturing capabilities and thus maintain their revenue share. Further, new competitors are also focusing on developing improved designs with advanced drug filling technologies, which is expected to help expand the market growth. For instance, on February 2020, SCHOTT extends syriQ BioPure syringe format to allow optimized administration. syriQ BioPure syringes are precisely manufactured to keep sensitive biologic drugs stable over their shelf life while easing the administration process for patients. The portfolio now includes a new 2.25mL syringe format, which supports both the drug’s and patient’s needs when it comes to administering highly viscous biologics by autoinjector. The new container format will be introduced at Pharmapack trade show in Paris, where SCHOTT is presenting its full range of pharmaceutical containers at booth D60.

• Schott AG
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Gerresheimer AG
• West Pharmaceutical Services, Inc.
• Becton, Dickinson and Company
• Vetter Pharma International GmbH
• Catalent, Inc.
• Shandong Weigao Group Medical Polymer Company Limited
• Nipro Corporation
• Medpro, Inc.
• Stevanato Group SpA

 “*” marked represents similar segmentation in other categories in the respective section